Filing Details
- Accession Number:
- 0001209191-18-017175
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-06 15:21:11
- Reporting Period:
- 2018-03-05
- Accepted Time:
- 2018-03-06 15:21:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 19411 | Magellan Health Inc | MGLN | Services-Hospitals (8060) | 581076937 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1647234 | Mostafa Kamal | 15950 North 76Th Street Suite 200 Scottsdale AZ 85260 | Ceo, Magellan Rx Management | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 1,480 | $63.95 | 1,480 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 7,307 | $64.87 | 8,787 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Acquisiton | 2018-03-05 | 6,641 | $68.50 | 15,428 | No | 4 | X | Direct | |
| Ordinary Common Stock, $0.01 Par Value | Disposition | 2018-03-05 | 15,428 | $99.04 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | X | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-05 | 1,480 | $0.00 | 1,480 | $63.95 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-05 | 7,307 | $0.00 | 7,307 | $64.87 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-03-05 | 6,641 | $0.00 | 6,641 | $68.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-03-03 | No | 4 | X | Direct | |
| 7,306 | 2026-03-03 | No | 4 | X | Direct | |
| 13,282 | 2027-03-03 | No | 4 | X | Direct |
Footnotes
- This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $98.30 to $101.05, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- All of the stock options in this tranche have vested in full.
- Not applicable.
- The remainder of 7,306 options shall vest on March 3, 2019.
- The remainder of 13,282 options shall vest in equal increments on March 3, 2019 and 2020.
Billionaire Hedge Funds
